A detailed history of Conestoga Capital Advisors, LLC transactions in Repligen Corp stock. As of the latest transaction made, Conestoga Capital Advisors, LLC holds 940,710 shares of RGEN stock, worth $138 Million. This represents 1.94% of its overall portfolio holdings.

Number of Shares
940,710
Previous 946,877 0.65%
Holding current value
$138 Million
Previous $119 Million 17.29%
% of portfolio
1.94%
Previous 1.81%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$119.79 - $167.35 $738,744 - $1.03 Million
-6,167 Reduced 0.65%
940,710 $140 Million
Q2 2024

Jul 26, 2024

BUY
$120.0 - $182.95 $23.9 Million - $36.5 Million
199,322 Added 26.66%
946,877 $119 Million
Q1 2024

Apr 26, 2024

BUY
$170.78 - $208.42 $6.46 Million - $7.88 Million
37,817 Added 5.33%
747,555 $137 Million
Q4 2023

Jan 26, 2024

BUY
$114.17 - $185.35 $295,700 - $480,056
2,590 Added 0.37%
709,738 $128 Million
Q3 2023

Oct 27, 2023

BUY
$138.78 - $176.51 $3.41 Million - $4.34 Million
24,593 Added 3.6%
707,148 $112 Million
Q2 2023

Jul 28, 2023

SELL
$138.42 - $180.31 $399,480 - $520,374
-2,886 Reduced 0.42%
682,555 $96.6 Million
Q1 2023

Apr 21, 2023

BUY
$154.26 - $198.1 $558,883 - $717,716
3,623 Added 0.53%
685,441 $115 Million
Q4 2022

Jan 31, 2023

BUY
$162.42 - $220.56 $122,627 - $166,522
755 Added 0.11%
681,818 $115 Million
Q3 2022

Oct 24, 2022

SELL
$160.42 - $256.21 $13.8 Million - $22.1 Million
-86,236 Reduced 11.24%
681,063 $127 Million
Q2 2022

Jul 22, 2022

SELL
$140.68 - $188.02 $762,485 - $1.02 Million
-5,420 Reduced 0.7%
767,299 $125 Million
Q1 2022

Apr 25, 2022

BUY
$161.19 - $257.96 $19.2 Million - $30.7 Million
118,818 Added 18.17%
772,719 $145 Million
Q4 2021

Jan 21, 2022

SELL
$247.59 - $304.47 $53.8 Million - $66.2 Million
-217,489 Reduced 24.96%
653,901 $173 Million
Q3 2021

Oct 22, 2021

SELL
$194.77 - $324.21 $29.6 Million - $49.2 Million
-151,885 Reduced 14.84%
871,390 $252 Million
Q2 2021

Jul 27, 2021

SELL
$165.87 - $220.95 $679,237 - $904,790
-4,095 Reduced 0.4%
1,023,275 $204 Million
Q1 2021

Apr 23, 2021

BUY
$180.37 - $226.26 $983,377 - $1.23 Million
5,452 Added 0.53%
1,027,370 $200 Million
Q4 2020

Jan 26, 2021

SELL
$148.08 - $206.57 $21.3 Million - $29.7 Million
-143,698 Reduced 12.33%
1,021,918 $196 Million
Q3 2020

Oct 23, 2020

BUY
$122.51 - $158.27 $6.95 Million - $8.98 Million
56,722 Added 5.12%
1,165,616 $172 Million
Q2 2020

Aug 03, 2020

SELL
$94.33 - $140.48 $22.1 Million - $32.9 Million
-233,945 Reduced 17.42%
1,108,894 $137 Million
Q1 2020

Apr 17, 2020

BUY
$84.96 - $109.14 $6.58 Million - $8.46 Million
77,505 Added 6.13%
1,342,839 $130 Million
Q4 2019

Jan 24, 2020

SELL
$73.84 - $93.08 $1.01 Million - $1.27 Million
-13,645 Reduced 1.07%
1,265,334 $117 Million
Q3 2019

Oct 25, 2019

SELL
$76.65 - $95.51 $32.1 Million - $40.1 Million
-419,350 Reduced 24.69%
1,278,979 $98.1 Million
Q2 2019

Aug 02, 2019

BUY
$54.2 - $85.95 $3.3 Million - $5.23 Million
60,899 Added 3.72%
1,698,329 $146 Million
Q1 2019

Apr 18, 2019

BUY
$49.45 - $62.8 $1.06 Million - $1.34 Million
21,393 Added 1.32%
1,637,430 $96.7 Million
Q4 2018

Jan 28, 2019

SELL
$48.26 - $68.88 $15.7 Million - $22.4 Million
-325,175 Reduced 16.75%
1,616,037 $85.2 Million
Q3 2018

Oct 25, 2018

BUY
$46.8 - $58.97 $10.8 Million - $13.6 Million
230,080 Added 13.45%
1,941,212 $108 Million
Q2 2018

Jul 20, 2018

BUY
$35.26 - $47.04 $3.78 Million - $5.04 Million
107,095 Added 6.68%
1,711,132 $80.5 Million
Q1 2018

Apr 24, 2018

SELL
$30.92 - $37.27 $2.03 Million - $2.44 Million
-65,525 Reduced 3.92%
1,604,037 $58 Million
Q4 2017

Jan 22, 2018

BUY
$32.53 - $38.92 $7.04 Million - $8.42 Million
216,330 Added 14.89%
1,669,562 $60.6 Million
Q3 2017

Oct 20, 2017

BUY
$36.98 - $46.06 $53.7 Million - $66.9 Million
1,453,232
1,453,232 $55.7 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Conestoga Capital Advisors, LLC Portfolio

Follow Conestoga Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.